Originally developed by Acceleron Pharma, sotatercept is the only drug to have achieved breakthrough therapy designation in the US for PAH.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,